P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

November 2010

Features

Letters to the Editor

Health Care and Law

Antipsychotic Medications Are Spelling Legal Trouble for Drugmakers

Makers of atypical antipsychotic medications are under scrutiny for promoting the off-label use of these agents, a practice that has led to serious adverse events and has cost the manufacturers billions of dollars in penalties.
Robert I. Field, JD, MPH, PhD

Personalized Medicine

Part 2: Ethical, Legal, and Regulatory Issues

The health care reform bill, privacy rules, health information technology, genetic testing, and a trend toward collaboration among federal agencies indicate that all stakeholders will have to change their business practices in the future.
F. Randy Vogenberg, PhD, RPh; Carol Isaacson Barash, PhD; and Michael Pursel, RPh, MBA

Commentary

Health Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals

With the passage of the Patient Protection and Affordable Care Act, five new categories of hospitals and clinics will be able to buy many drugs at reduced prices.
Stephen Barlas

Meeting Highlights

Transcatheter Cardiovascular Therapeutics Conference 2010 and Second World Parkinson Congress

Sessions of the cardiovascular conference addressed the effect of statins on myocardial infarction, the safety of atopaxar (E5555) in acute coronary syndromes, and a comparison of clopidogrel (Plavix) and Prasugrel (Effient). The Parkinson meeting featured gastrointestinal absorption and the value of paroxetine (Paxil), venlafaxine (Effexor), and ritigotine (Neupro) in patients’ quality of life.
Walter Alexander

Pharmaceutical Approval Update

Topics include fingolimod capsules (Gilenya) for patients with relapsing multiple sclerosis; pegloticase (Krystexxa), an injectable product for gout; and Beyaz, a formulation of Yaz, an oral contraceptive that includes a folate vitamin to reduce the risk of neural tube defects.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

Target Quality

Thomas Jefferson University Hospital is working to reduce adverse events by using anticoagulation management, a pharmacy service line approach, and technology to enhance patient safety.
David B. Nash, MD, MBA

Medication Errors

Remote Computerized Prescriber Entry Errors—More Than 'Remotely' Possible

Mistakes in prescribing, dispensing, and administering drugs are more likely when the agent is ordered from a remote location and when procedures are not reviewed.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

The Avenue to Discounts for Non-Profit Hospital Pharmacies

Meeting the Requirements of the Non-Profit Institutions Act

Changes in the government’s drug pricing program, along with the Non-Profit Institutions Act exemption, may enable hospital pharmacies to buy drugs at a lower cost.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, new drug ­indications, and updates

Drug Forecast

Estradiol Valerate and Estradiol Valerate/Dienogest (Natazia) Tablets

The First Four-Phasic Oral Contraceptive

Natazia, a four-phasic oral contraceptive
Uche Anadu Ndefo, PharmD, BCPS; and Nina Mosely, PharmD Candidate